Records containing: Pancreatic Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-02-16Stereotactic Body Radiation Therapy Plus Pembrolizumab and Trametinib vs. Stereotactic Body Radiation Therapy Plus Gemcitabine for Locally Recurrent Pancreatic Cancer After Surgical Resection: an Open-label, Randomized, Controlled, Phase 2 Trial
-
CLINICAL_TRIALS study record update · 2021-02-12Prevalence of Germline Pathogenic Mutations in Patients With Pancreatic Adenocarcinoma
-
CLINICAL_TRIALS study record update · 2021-02-10Phase II Study of Radiation Therapy With Anti-PD-1 Antibody in Treating Patients With Unresectable Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2021-02-08Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer: Establishing the Radiomic/Pathologic Foundation of Heterogeneity
-
CLINICAL_TRIALS study record update · 2021-02-04A Phase II Trial of TAS-102 (Lonsurf) in Patients With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma After Progression Through First Line Chemotherapy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-02-04Study of Autologous T-cells Redirected to Mesothelin With a Chimeric Antigen Receptor in Patients With Metastatic Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2021-02-02Phase II Study of Neoadjuvant Accelerated Short Course Radiation Therapy With Proton or Photon RT Plus Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2021-01-22Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2021-01-22An Open-label, Phase II Study of Intravenous Anetumab Ravtansine (BAY 94-9343), an Anti-mesothelin Antibody Drug Conjugate, in Pretreated Mesothelin-expressing Advanced Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2021-01-19Detection of Pancreatic Cancer and Pre-cancer by Stool DNA Testing: A Feasibility Study
-
CLINICAL_TRIALS study record update · 2021-01-12Comparison Of Radiation Exposure To Patients During ERCPs Performed By Endoscopists Trained In Judicious Use Of Fluoroscopy With Those Without Formal Training
-
CLINICAL_TRIALS study record update · 2021-01-08Clinical Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin in Patients With Unresectable Locally Advanced Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2021-01-06Evaluation of Contrast Enhanced Intraoperative Ultrasound (CE-IOUS) as a Clinical Decision-making Tool for Patients With Pancreatic Cancer Undergoing Surgery: A Prospective, Proof-of-concept Trial
-
CLINICAL_TRIALS study record update · 2021-01-05CPET-Panc: Exercise Testing in Chemotherapy
-
CLINICAL_TRIALS study record update · 2020-12-31A Phase I Study to Assess the Tolerability, Safety and Efficacy of Fluzoparib in Combination With mFOLFIRINOX as Neoadjuvant and Adjuvant Therapy in Patients With Resectable Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2020-12-30IIT2018-26 -Hendifar-NETCx: A Descriptive, Multicenter, Single-arm, Open Label Study to Analyze the Effect of Telotristat Ethyl on Weight Regulation/Gain
-
CLINICAL_TRIALS study record update · 2020-12-30A Phase I Study of Onivyde and 5-FU in Combination With Xilonix for Advanced Pancreatic Cancer With Cachexia
-
CLINICAL_TRIALS study record update · 2020-12-29Surgery/Destruction for Stage IV Pancreatic Cancer With Oligo-Metastatic Disease
-
CLINICAL_TRIALS study record update · 2020-12-23A Phase I/II, Open-label, One-arm, Single-center Study to Evaluate the Safety and Efficacy of the Pan-immunotherapy in Subjects With Local Advanced/Metastatic Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2020-12-19A Phase Ib, Open-label, Multicenter, Dose-escalation, Safety and Tolerability Study of LDE225 in Combination With Gemcitabine in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
-
CLINICAL_TRIALS study record update · 2020-12-09Comparison of Traditional Back-loaded Fiducial Needles With Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement for Image-guided Radiation Therapy in Patients With Pancreatic Cancer: A Multicenter Randomized Controlled Trial.
-
CLINICAL_TRIALS study record update · 2020-12-08Improving Outcomes in Patients With Hepatobiliary and Pancreatic Cancers With a Nutritional and Physical Conditioning Prehabilitation Program
-
CLINICAL_TRIALS study record update · 2020-12-03Phase 2 Multicenter, Open-Label Study of CS-1008, A Humanized Monoclonal Antibody Targeting Death Receptor 5 (DR5), In Combination With Gemcitabine in Chemotherapy Naive Subjects With Unresectable or Metastatic Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2020-11-23A Head-to-head Comparison of a Novel Silicon Microsieve Device Against a Cell Surface Marker-based Platform for the Isolation of Portal Vein Circulating Tumor Cells in Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2020-11-19Phase I: PET Imaging of Tissue Factor (TF) Expression in Patients With Primary and Metastastic Cancer Using 18F-ASIS.